Technical Analysis for MEDXF - Medexus Pharmaceuticals Inc

Grade Last Price % Change Price Change
grade A 4.285 0.82% 0.0350
MEDXF closed up 0.82 percent on Tuesday, December 1, 2020, on 1.44 times normal volume. It was able to find support at its 50 day moving average. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Up Up
Historical MEDXF trend table...

Date Alert Name Type % Chg
New Downtrend Bearish 0.00%
1,2,3 Retracement Bearish Bearish Swing Setup 0.00%
20 DMA Support Bullish 0.00%
50 DMA Support Bullish 0.00%
Expansion Pivot Buy Setup Bullish Swing Setup 0.00%
Wide Range Bar Range Expansion 0.00%
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Narrow Range Bar Range Contraction 0.82%
Older End-of-Day Signals for MEDXF ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Medexus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada and the United States. The company's primary products are Rasuvo and Metoject, a formulation of methotrexate designed to treat rheumatoid arthritis and other auto-immune diseases; IXINITY, an intravenous recombinant factor IX therapeutic for use in patients 12 years of age or older with Hemophilia B; and Rupall, which is indicated for the treatment of seasonal allergic rhinitis, perennial allergic rhinitis, and chronic spontaneous urticaria in patients 2 years of age and older. Its products portfolio also include Cuvposa, which is indicated for sialorrhea in patients aged 3-18 years with neurologic conditions, such as cerebral; Gliolan, an orally administered drug used for the visualization of various brain tumors; and Treosulfan, a conditioning agent used prior to stem cell transplantation. The company was formerly known as Pediapharm Inc. and changed its name to Medexus Pharmaceuticals Inc. in December 2018. Medexus Pharmaceuticals Inc. is based in Verdun, Canada.
Medical Specialties RTT Clinical Medicine Pharmaceutical Immunology Allergy Rheumatoid Arthritis Transplantation Allergology Allergic Rhinitis Rhinitis Brain Tumors Immunosuppressants Seasonal Allergic Rhinitis

Is MEDXF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 4.43
52 Week Low 2.01
Average Volume 5,565
200-Day Moving Average 0.0000
50-Day Moving Average 3.4439
20-Day Moving Average 3.8452
10-Day Moving Average 4.1230
Average True Range 0.2833
ADX 32.16
+DI 29.7027
-DI 37.0085
Chandelier Exit (Long, 3 ATRs ) 3.5801
Chandelier Exit (Short, 3 ATRs ) 3.9999
Upper Bollinger Band 4.5758
Lower Bollinger Band 3.1146
Percent B (%b) 0.8
BandWidth 38.0006
MACD Line 0.2583
MACD Signal Line 0.2265
MACD Histogram 0.0318
Fundamentals Value
Market Cap 61.94 Million
Num Shares 14.5 Million
EPS
Price-to-Sales 0.85
Price-to-Book 3.22
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.0100
Resistance 3 (R3) 5.8367 5.0883 5.7225
Resistance 2 (R2) 5.0883 4.6490 5.1750 5.6266
Resistance 1 (R1) 4.6867 4.3776 4.8875 4.8600 5.5308
Pivot Point 3.9383 3.9383 4.0388 4.0250 3.9383
Support 1 (S1) 3.5367 3.4990 3.7375 3.7100 3.0392
Support 2 (S2) 2.7883 3.2276 2.8750 2.9434
Support 3 (S3) 2.3867 2.7883 2.8475
Support 4 (S4) 2.5600